A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF A SELECTIVE, ORAL SPHINGOSINE 1-PHOSPHATE RECEPTOR MODULATOR, ETRASIMOD (APD334), IN MODERATE TO SEVERE ULCERATIVE COLITIS: RESULTS FROM THE OASIS STUDY

William Sandborn  1     Laurent Peyrin-Biroulet  2     Luba Trokan  3     Jinkun Zhang  3     Tanja Kühbacher  4     Michael Chiorean  5     Scott D. Lee  6     Severine Vermeire     Bruce Yacyshyn     Snehal U. Naik     Preston Klassen     Julian Panés    
1 University of California San Diego,San Diego,United States
2 Lorraine University,Nancy,France
3 Arena Pharmaceuticals,San Diego,United States
4 Asklepio Westklinikum Hamburg,Hamburg,Germany
5 Virginia Mason Medical Center,Seattle,United States
6 University of Washington Medical Center,Seattle

Conference
UEG Week 2018

Citation
United European Gastroenterology Journal 2018; 6 (Supplement 1)

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing